Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling
2020 · Journal of Experimental & Clinical Cancer Research · 32 citations
https://doi.org/10.1186/s13046-020-01750-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
65
Citations
2
h-index
2
i10-index
Dongze Xu is an academic researcher from First Affiliated Hospital of Xi'an Jiaotong University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Microtubule and mitosis dynamics & RNA Research and Splicing. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat